STADA at a Glance
Sales companies
Sales companies Germany
Denmark 
Print page
Send page
Bookmark page
STADA as homepage
International sales activities
Denmark
The Danish sales company PharmaCoDane ApS, Copenhagen, has been a member of the STADA Group since 1998.
In Denmark, sales decreased by 9% in 2011 applying the exchange rates of the previous year. In euro, sales also decreased by 9% at EUR 31.4 million (previous year: EUR 34.4 million).
This sales development was primarily due to a reduction in the traditional business activities of parallel imports in this local market, which belongs to the commercial business. Sales in the commercial business reduced by 18% in Denmark in financial year 2011 to EUR 22.2 million (previous year: EUR 27.0 million). The commercial business thus made a contribution of 71% (previous year: 78%) to Danish STADA sales.
Sales with generics increased by 49% to EUR 6.9 million in 2011 (previous year: EUR 4.7 million) in the Danish market. This gave branded products a share of local sales of 22% (previous year: 14%). With a market share in the amount of approx. 3.2% (previous year: approx. 2.8%), the Danish STADA subsidiary occupied position 8 in the local generics market in the financial year 2011.1)
Sales of Danish STADA branded products went down by 19% in the financial year 2011 to EUR 2.3 million (previous year: EUR 2.8 million). This represents a share of local Group sales of 7% (previous year: 8%).
Operating profitability in the Danish market in 2011 was, as planned, again below Group average, as activities, as described above, predominantly include commercial business with the usual low margins.
For financial year 2012, the Group expects sales in Denmark to stabilize for the core segments with an operating profitability which continues to be below Group average; due to the reduction strived for in low-margin non-core activities, sales will decrease overall in this national market as planned.
| 1) | STADA estimate based on IMS Health data at ex-factory prices. |
